Skip to main content
OpenTrials

Clinical trial condition

Systemic Sclerosis, Scleroderma

Explore clinical trials studying Systemic Sclerosis, Scleroderma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Systemic Sclerosis, Scleroderma trial results

Completed

Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis

NCT00613171

Conditions
Connective Tissue Diseases, Fibrosis, Pathologic Processes, +6 more
Locations
  • Novartis Investigator Site Chicago, Illinois, United States
  • Novartis Investigator Site Baltimore, Maryland, United States
  • Novartis Investigator Site Boston, Massachusetts, United States
  • Novartis Investigator Site Erlangen, Germany
View Trial Details

Related conditions